[Real day in neonatology: JALON 2001, Nancy, October 6 2001. Fentanyl-ORL 1 receptor interactions in the perinatal period: should the "principle of precaution" be applied to premature newborns?].
Laudenbach
V
V
Laboratoire de neurologie du développement, INSERM E 9935, hôpital Robert-Debré, Paris, France.
Gressens
P
P
D000701:Analgesics, Opioid / Q000493:pharmacokinetics / Q000494:pharmacology*; D000818:Animals; D004195:Disease Models, Animal; D005283:Fentanyl / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007969:Leukomalacia, Periventricular / Q000150:complications; D051379:Mice; D010146:Pain / Q000188:drug therapy*; D017288:Pain Threshold / Q000502:physiology*; D011957:Receptors, Opioid / Q000187:drug effects* / Q000502:physiology; D000094942:Nociceptin Receptor
D000701:Analgesics, Opioid; D011957:Receptors, Opioid; D005283:Fentanyl; D000094942:Nociceptin Receptor